Free Trial

Bridgepoint Group (LON:BPT) Given Overweight Rating at JPMorgan Chase & Co.

Bridgepoint Group logo with Financial Services background

Key Points

  • JPMorgan Chase & Co. has reaffirmed an "overweight" rating for Bridgepoint Group, setting a target price of GBX 424 ($5.66), indicating a potential upside of 23.42%.
  • Deutsche Bank has reiterated a "hold" rating for Bridgepoint Group with a lower target price of GBX 345 ($4.61).
  • Bridgepoint Group currently has a market capitalization of £2.84 billion and a notable price-to-earnings ratio of 62.41.
  • Interested in Bridgepoint Group? Here are five stocks we like better.

Bridgepoint Group (LON:BPT - Get Free Report)'s stock had its "overweight" rating reissued by equities research analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday, MarketBeat.com reports. They currently have a GBX 424 ($5.70) price objective on the stock. JPMorgan Chase & Co.'s price objective indicates a potential upside of 22.46% from the company's current price.

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a GBX 345 ($4.64) price target on shares of Bridgepoint Group in a research report on Monday, July 21st.

Get Our Latest Stock Report on BPT

Bridgepoint Group Stock Up 1.3%

Shares of LON BPT traded up GBX 4.33 ($0.06) during midday trading on Thursday, hitting GBX 346.23 ($4.65). 435,103 shares of the company's stock were exchanged, compared to its average volume of 1,782,923. The company has a market cap of £2.86 billion, a PE ratio of 62.90, a P/E/G ratio of 0.61 and a beta of 1.72. Bridgepoint Group has a twelve month low of GBX 229.20 ($3.08) and a twelve month high of GBX 410 ($5.51). The firm's fifty day simple moving average is GBX 314.06 and its 200-day simple moving average is GBX 314.49. The company has a debt-to-equity ratio of 12.89, a current ratio of 4.98 and a quick ratio of 3.60.

Bridgepoint Group Company Profile

(Get Free Report)

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.

Featured Stories

Should You Invest $1,000 in Bridgepoint Group Right Now?

Before you consider Bridgepoint Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bridgepoint Group wasn't on the list.

While Bridgepoint Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.